MCAP.ST Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (6 mai 2024 @ 17:29):

MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, growth capital, middle market, mature, turnarounds, buyout...

Stats
Dagens volum	16 614.00
Gjennomsnittsvolum	13 860.00
Markedsverdi	6.96B
EPS	SEK0 ( 2024-05-02 )
Neste inntjeningsdato	( SEK0 ) 2024-07-19
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	40.52
ATR14	SEK0.742 (0.16%)

Volum Korrelasjon

Lang: -0.01 (neutral)

Kort: -1.00 (very strong negative)

Signal:(56.029) Neutral

MedCap AB (publ) Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

MedCap AB (publ) Korrelasjon - Valuta/Råvare

0.02
( neutral )

-0.09
( neutral )

0.02
( neutral )

-0.23
( neutral )

0.16
( neutral )

MedCap AB (publ) Økonomi

Annual	2023
Omsetning:	SEK1.59B
Bruttogevinst:	SEK221.50M (13.95 %)
EPS:	SEK11.63

FY	2023
Omsetning:	SEK1.59B
Bruttogevinst:	SEK221.50M (13.95 %)
EPS:	SEK11.63

FY	2022
Omsetning:	SEK1.11B
Bruttogevinst:	SEK462.40M (41.61 %)
EPS:	SEK7.94

FY	2021
Omsetning:	SEK916.30M
Bruttogevinst:	SEK369.80M (40.36 %)
EPS:	SEK0.920

Financial Reports:

No articles found.

MedCap AB (publ)

MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, growth capital, middle market, mature, turnarounds, buyout. It prefers to invest in healthcare equipment and services, biotechnology, life sciences, and pharmaceuticals companies. The firm prefers to invest in small to medium size companies that are not listed on the stock exchange and are based in Northern Europe. It typically invests between SEK25 million ($2.75 million) to SEK150 million ($16.51 million) with enterprise value and sales revenue between SEK50 million ($5.90 million) to SEK200 million ($23.06 million) and EBITDA between SEK1 million ($0.11 million) to SEK50 million ($5.50 million). The firm seeks to acquire stakes between 20% and 50% in its portfolio companies. It uses its capital and loans and makes balance sheet investments. MedCap AB (publ) was founded in 2001 and is based in Stockholm, Sweden.